APELLIS PHARMACEUTICALS INC's ticker is and the CUSIP is 03753U956. A total of 6 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,509 | -53.4% | 223,700 | +11.6% | 0.01% | -53.3% |
| Q2 2023 | $18,265 | +157.6% | 200,500 | +86.5% | 0.02% | +150.0% |
| Q1 2023 | $7,090 | +121.9% | 107,500 | +73.9% | 0.01% | +100.0% |
| Q4 2022 | $3,195 | -99.9% | 61,800 | -5.9% | 0.00% | -40.0% |
| Q3 2022 | $4,487,000 | +451.9% | 65,700 | +265.0% | 0.01% | +400.0% |
| Q2 2022 | $813,000 | -54.3% | 18,000 | -48.6% | 0.00% | -50.0% |
| Q1 2022 | $1,778,000 | +1161.0% | 35,000 | +1066.7% | 0.00% | – |
| Q4 2021 | $141,000 | -59.1% | 3,000 | -41.2% | 0.00% | – |
| Q3 2021 | $345,000 | +9.2% | 5,100 | +2.0% | 0.00% | – |
| Q2 2021 | $316,000 | -4.2% | 5,000 | +6393.5% | 0.00% | -100.0% |
| Q1 2021 | $330,000 | – | 77 | -85.0% | 0.00% | – |
| Q4 2020 | $0 | – | 513 | +51200.0% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 1 | -99.4% | 0.00% | -100.0% |
| Q2 2020 | $542,000 | -43.1% | 166 | -53.4% | 0.00% | -50.0% |
| Q1 2020 | $953,000 | +47.5% | 356 | +68.7% | 0.00% | +100.0% |
| Q4 2019 | $646,000 | +1245.8% | 211 | +955.0% | 0.00% | – |
| Q3 2019 | $48,000 | – | 20 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 96,800 | $4,377,000 | 0.01% |
| JANE STREET GROUP, LLC | 130,000 | $5,879,000 | 0.00% |
| SIMPLEX TRADING, LLC | 18,000 | $813,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |